MLAB icon

Mesa Laboratories

103.40 USD
+2.77
2.75%
At close Jul 3, 4:00 PM EDT
After hours
103.40
+0.00
0.00%
1 day
2.75%
5 days
6.55%
1 month
3.28%
3 months
-4.60%
6 months
-25.26%
Year to date
-21.65%
1 year
14.36%
5 years
-53.49%
10 years
14.29%
 

About: Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Employees: 730

0
Funds holding %
of 7,310 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

1.17% more ownership

Funds ownership: 93.99% [Q4 2024] → 95.17% (+1.17%) [Q1 2025]

8% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 51

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 156 [Q4 2024] → 151 (-5) [Q1 2025]

9% less capital invested

Capital invested by funds: $673M [Q4 2024] → $613M (-$59.8M) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$100
3%
downside
Avg. target
$100
3%
downside
High target
$100
3%
downside

1 analyst rating

positive
0%
neutral
0%
negative
100%
Wells Fargo
Brandon Couillard
3%downside
$100
Underweight
Maintained
30 May 2025

Financial journalist opinion

Neutral
GlobeNewsWire
13 hours ago
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., July 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.
MESA LABS DECLARES QUARTERLY DIVIDEND
Neutral
GlobeNewsWire
1 day ago
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025.
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
Negative
Zacks Investment Research
1 month ago
Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $2.23 per share, missing the Zacks Consensus Estimate of $2.75 per share. This compares to earnings of $2.77 per share a year ago.
Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
Neutral
GlobeNewsWire
1 month ago
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q25”) and full fiscal year (“FY25”) ended March 31, 2025 (amounts in thousands).
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
Neutral
GlobeNewsWire
2 months ago
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025.
MESA LABS DECLARES QUARTERLY DIVIDEND
Negative
Investors Business Daily
3 months ago
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Tariff uncertainty has cast a pall over medical stocks. Re-shoring is possible, but expensive, leaving them in a "wait-and-see" pattern.
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Positive
Zacks Investment Research
3 months ago
What Makes Mesa Labs (MLAB) a New Strong Buy Stock
Mesa Labs (MLAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
What Makes Mesa Labs (MLAB) a New Strong Buy Stock
Positive
Zacks Investment Research
4 months ago
Why Mesa Labs (MLAB) Might be Well Poised for a Surge
Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Mesa Labs (MLAB) Might be Well Poised for a Surge
Positive
Zacks Investment Research
4 months ago
Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates
Mesa Labs (MLAB) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.45 per share. This compares to earnings of $2.02 per share a year ago.
Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates
Neutral
GlobeNewsWire
4 months ago
Mesa Labs Announces Third Quarter Results
LAKEWOOD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarter (“3Q25”) ended December 31, 2024 (amounts in thousands).
Mesa Labs Announces Third Quarter Results
Charts implemented using Lightweight Charts™